Breaking News Instant updates and real-time market news.

PM

Philip Morris

$72.43 /

-2.755 (-3.66%)

13:39
06/11/20
06/11
13:39
06/11/20
13:39

Philip Morris sees Q2 EPS at upper end of $1.00-$1.10, consensus $1.09

Shares of Philip Morris are trading lower by $3.00 per share or almost 4% to $72.20 per share in afternoon trading on Thursday after providing guidance earlier. The company said in a statement ahead of an investor conference that the company is on-track to deliver second-quarter reported diluted EPS toward the upper end of its previously communicated range of $1.00 to $1.10, provided on Tuesday, April 21st. Current consensus is $1.09 for the quarter.The forecast includes an unfavorable currency impact, at prevailing exchange rates, of approximately 7c per share, compared to an unfavorable impact of approximately 12c per share, communicated previously. "The forecast assumes a currency-neutral net revenue decline - wholly attributable to COVID-19-related factors - around the high end of the company's previously communicated decline range of 8% to 12%. This primarily reflects industry cigarette volume declines at the high end of our initial estimates due to stricter or longer lockdowns in certain Latin America and EU markets during April and May. We have observed, however, better-than-anticipated IQOS performance and, in recent weeks, signs of recovery for combustible products. The forecast also assumes no disruption in the company's ability to supply its customers, based on its current operations and inventory levels. "Until PMI is able to estimate the full-year 2020 impact of COVID-19 on its business with greater certainty, the company plans to continue providing quarterly forecasts on a one quarter forward basis, with the exception of the following items forecasted for the full year: capital expenditures of approximately $0.7 billion, compared to approximately $0.8 billion disclosed previously; and an effective tax rate of approximately 23%, subject to changes in full-year earnings mix. The company will issue its 2020 second-quarter results on Tuesday, July 21st," said the company in a statement.

  • 21

    Jul

PM Philip Morris
$72.43 /

-2.755 (-3.66%)

04/03/20 Panmure Gordon
Philip Morris upgraded to Buy from Hold at Panmure Gordon
04/01/20 Goldman Sachs
Philip Morris resumed with a Buy at Goldman Sachs
03/23/20 Piper Sandler
Philip Morris recent share selloff looks overdone, says Piper Sandler
02/13/20
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks
Regeneron announces start of REGN-COV2 Phase 3 COVID-19 prevention trial » 07:06
07/06/20
07/06
07:06
07/06/20
07:06
REGN

Regeneron

$620.76 /

+11.54 (+1.89%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

  • 27
    May
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

Hot Stocks
Staar Surgical announces Patrick Williams as CFO » 07:05
07/06/20
07/06
07:05
07/06/20
07:05
STAA

Staar Surgical

$61.70 /

+1.29 (+2.14%)

Staar Surgical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STAA Staar Surgical
$61.70 /

+1.29 (+2.14%)

STAA Staar Surgical
$61.70 /

+1.29 (+2.14%)

06/24/20 BTIG
Staar Surgical downgraded to Neutral from Buy at BTIG
06/15/20 Jefferies
Staar Surgical initiated with a Buy at Jefferies
03/04/20
BTIG healthcare analysts to hold an analyst/industry conference call
01/31/20 Benchmark
Too early to call China emergency impact on Staar Surgical, says Benchmark
STAA Staar Surgical
$61.70 /

+1.29 (+2.14%)

General news
FX Update: Risk-on positioning has been ensuing » 07:05
07/06/20
07/06
07:05
07/06/20
07:05

FX Update: Risk-on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Sally Beauty reports preliminary Q3 revenue $705M, consensus $653.39M  07:03
07/06/20
07/06
07:03
07/06/20
07:03
SBH

Sally Beauty

$13.08 /

+0.17 (+1.32%)

 
ShowHide Related Items >><<
SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform at Oppenheimer
06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform from Perform at Oppenheimer
04/27/20 DA Davidson
Sally Beauty price target lowered to $10 from $14.50 at DA Davidson
04/20/20 Raymond James
Sally Beauty preliminary Q2 not as bad as feared, says Raymond James
SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

Syndicate
Akero announces proposed public offering of 4.75M shares of common stock » 07:03
07/06/20
07/06
07:03
07/06/20
07:03
AKRO

Akero Therapeutics

$33.13 /

-0.36 (-1.07%)

J.P. Morgan Securities,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

Hot Stocks
Regeneron announces start of REGN-COV2 Phase 3 COVID-19 prevention trial  07:03
07/06/20
07/06
07:03
07/06/20
07:03
REGN

Regeneron

$620.76 /

+11.54 (+1.89%)

 
ShowHide Related Items >><<
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

  • 27
    May
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

Syndicate
Vir Biotechnology files to sell 6.2M shares of common stock » 07:02
07/06/20
07/06
07:02
07/06/20
07:02
VIR

Vir Biotechnology

$40.27 /

+0.65 (+1.64%)

Goldman Sachs & Co.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIR Vir Biotechnology
$40.27 /

+0.65 (+1.64%)

VIR Vir Biotechnology
$40.27 /

+0.65 (+1.64%)

05/13/20 Barclays
Vir Biotechnology price target raised to $44 from $41 at Barclays
03/19/20 JPMorgan
JPMorgan downgrades Vir Biotechnology to Underweight after 290% rally
03/19/20 JPMorgan
Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan
03/13/20 Goldman Sachs
Vir Biotechnology downgraded to Neutral from Buy at Goldman Sachs
VIR Vir Biotechnology
$40.27 /

+0.65 (+1.64%)

  • 11
    Oct
VIR Vir Biotechnology
$40.27 /

+0.65 (+1.64%)

VIR Vir Biotechnology
$40.27 /

+0.65 (+1.64%)

VIR Vir Biotechnology
$40.27 /

+0.65 (+1.64%)

Upgrade
Infosys upgraded to Conviction Buy from Buy at Goldman Sachs » 07:02
07/06/20
07/06
07:02
07/06/20
07:02
INFY

Infosys

$9.92 /

+0.23 (+2.37%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFY Infosys
$9.92 /

+0.23 (+2.37%)

INFY Infosys
$9.92 /

+0.23 (+2.37%)

04/20/20 Stifel
Near-term will be difficult for Infosys, opportunity exists, says Stifel
02/20/20 JPMorgan
JPMorgan names Infosys top pick in India IT Services, Wipro top avoid
02/20/20 JPMorgan
Infosys initiated with an Overweight at JPMorgan
02/17/20 Goldman Sachs
Infosys upgraded to Buy from Neutral at Goldman Sachs
INFY Infosys
$9.92 /

+0.23 (+2.37%)

Hot Stocks
Becton Dickinson launches portable, rapid point-of-care COVID-19 antigen test » 07:01
07/06/20
07/06
07:01
07/06/20
07:01
BDX

Becton Dickinson

$245.09 /

+3.57 (+1.48%)

BD announced that the FDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

  • 21
    May
BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

Hot Stocks
Sally Beauty provides update on COVID-19 impact » 07:00
07/06/20
07/06
07:00
07/06/20
07:00
SBH

Sally Beauty

$13.08 /

+0.17 (+1.32%)

Sally Beauty provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform at Oppenheimer
06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform from Perform at Oppenheimer
04/27/20 DA Davidson
Sally Beauty price target lowered to $10 from $14.50 at DA Davidson
04/20/20 Raymond James
Sally Beauty preliminary Q2 not as bad as feared, says Raymond James
SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

Recommendations
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline » 07:00
07/06/20
07/06
07:00
07/06/20
07:00
D

Dominion

$82.68 /

+0.32 (+0.39%)

, BRK.A

Berkshire Hathaway

$267,661.14 /

+751.14 (+0.28%)

, DUK

Duke Energy

$81.84 /

-0.1 (-0.12%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

DUK Duke Energy
$81.84 /

-0.1 (-0.12%)

D Dominion
$82.68 /

+0.32 (+0.39%)

06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
05/29/20 Wolfe Research
Dominion downgraded to Peer Perform from Outperform at Wolfe Research
05/14/20 Credit Suisse
Dominion price target raised to $85 from $80 at Credit Suisse
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
DUK Duke Energy
$81.84 /

-0.1 (-0.12%)

06/09/20 Seaport Global
Duke Energy initiated with a Neutral at Seaport Global
05/20/20 Wells Fargo
Duke Energy price target lowered to $88 from $108 at Wells Fargo
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
03/12/20 Barclays
Duke Energy downgraded to Equal Weight from Overweight at Barclays
D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

DUK Duke Energy
$81.84 /

-0.1 (-0.12%)

  • 19
    Nov
D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

DUK Duke Energy
$81.84 /

-0.1 (-0.12%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

DUK Duke Energy
$81.84 /

-0.1 (-0.12%)

D Dominion
$82.68 /

+0.32 (+0.39%)

DUK Duke Energy
$81.84 /

-0.1 (-0.12%)

Hot Stocks
Merck announces new analyses from islatravir trial » 06:57
07/06/20
07/06
06:57
07/06/20
06:57
MRK

Merck

$78.79 /

+0.67 (+0.86%)

Merck announced new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.79 /

+0.67 (+0.86%)

MRK Merck
$78.79 /

+0.67 (+0.86%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
MRK Merck
$78.79 /

+0.67 (+0.86%)

MRK Merck
$78.79 /

+0.67 (+0.86%)

MRK Merck
$78.79 /

+0.67 (+0.86%)

MRK Merck
$78.79 /

+0.67 (+0.86%)

Upgrade
Atresmedia upgraded to Overweight on ad momentum at JPMorgan » 06:57
07/06/20
07/06
06:57
07/06/20
06:57
ATVDY

Atresmedia

$0.00 /

+ (+0.00%)

JPMorgan analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVDY Atresmedia
$0.00 /

+ (+0.00%)

07/03/20 JPMorgan
Atresmedia upgraded to Overweight from Neutral at JPMorgan
05/18/20 Berenberg
Atresmedia price target lowered to EUR 2.80 from EUR 3.60 at Berenberg
04/28/20 Barclays
Atresmedia price target lowered to EUR 2.50 from EUR 2.70 at Barclays
04/20/20 JPMorgan
Atresmedia price target lowered to EUR 2.68 from EUR 2.71 at JPMorgan
Initiation
Endeavour Mining resumed with an Outperform at BMO Capital » 06:57
07/06/20
07/06
06:57
07/06/20
06:57
EDVMF

Endeavour Mining

$0.00 /

+ (+0.00%)

BMO Capital analyst Raj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDVMF Endeavour Mining
$0.00 /

+ (+0.00%)

EDVMF Endeavour Mining
$0.00 /

+ (+0.00%)

06/29/20 CIBC
Endeavour Mining price target raised to C$42 from C$40 at CIBC
06/25/20 CIBC
Endeavour Mining initiated with an Outperformer at CIBC
06/10/20 Berenberg
Endeavour Mining price target raised to C$36 from C$34 at Berenberg
05/19/20 National Bank
Endeavour Mining price target raised to C$42 from C$36 at National Bank
Recommendations
Tesla price target raised to $1,500 from $1,050 at JMP Securities » 06:51
07/06/20
07/06
06:51
07/06/20
06:51
TSLA

Tesla

$1,208.00 /

+88.84 (+7.94%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

06:41 Today JPMorgan
Tesla price target raised to $295 from $275 at JPMorgan
07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

  • 14
    Feb
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

Hot Stocks
Argo Group announces update to leadership team responsibilities, CFO search » 06:48
07/06/20
07/06
06:48
07/06/20
06:48
ARGO

Argo Group

$33.59 /

-0.23 (-0.68%)

Argo Group announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARGO Argo Group
$33.59 /

-0.23 (-0.68%)

ARGO Argo Group
$33.59 /

-0.23 (-0.68%)

05/15/20 Boenning & Scattergood
Argo Group upgraded to Outperform from Neutral at Boenning & Scattergood
05/15/20 Raymond James
Argo Group price target lowered to $45 from $55 at Raymond James
12/24/19 Keefe Bruyette
Argo Group highlighted as holiday opportunity at Keefe Bruyette
11/12/19
Fly Intel: Top five analyst upgrades
ARGO Argo Group
$33.59 /

-0.23 (-0.68%)

Recommendations
XPO Logistics price target raised to $75 from $65 at Barclays » 06:46
07/06/20
07/06
06:46
07/06/20
06:46
XPO

XPO Logistics

$76.50 /

-0.01 (-0.01%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

06/17/20 Deutsche Bank
XPO Logistics price target raised to $88 from $84 at Deutsche Bank
06/17/20 Deutsche Bank
XPO Logistics named short-term buy idea at Deutsche Bank
06/10/20 Morgan Stanley
Morgan Stanley starts 'undervalued' TFI International at Overweight
05/07/20 Deutsche Bank
XPO Logistics price target raised to $84 from $78 at Deutsche Bank
XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

Recommendations
Sunrun price target raised to $31 from $19 at JMP Securities » 06:45
07/06/20
07/06
06:45
07/06/20
06:45
RUN

Sunrun

$20.00 /

+0.165 (+0.83%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUN Sunrun
$20.00 /

+0.165 (+0.83%)

RUN Sunrun
$20.00 /

+0.165 (+0.83%)

06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
05/28/20 JPMorgan
Sunrun price target raised to $22 from $20 at JPMorgan
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
RUN Sunrun
$20.00 /

+0.165 (+0.83%)

RUN Sunrun
$20.00 /

+0.165 (+0.83%)

RUN Sunrun
$20.00 /

+0.165 (+0.83%)

Upgrade
Kimco Realty upgraded to Buy from Hold at Deutsche Bank » 06:45
07/06/20
07/06
06:45
07/06/20
06:45
KIM

Kimco Realty

$12.77 /

-0.15 (-1.16%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KIM Kimco Realty
$12.77 /

-0.15 (-1.16%)

KIM Kimco Realty
$12.77 /

-0.15 (-1.16%)

07/02/20 Citi
Kimco Realty price target raised to $14 from $9 at Citi
07/01/20 Goldman Sachs
Kimco Realty resumed with a Buy at Goldman Sachs
06/19/20 Mizuho
Kimco Realty price target raised to $13 from $10.50 at Mizuho
06/15/20
Fly Intel: Top five analyst downgrades
KIM Kimco Realty
$12.77 /

-0.15 (-1.16%)

KIM Kimco Realty
$12.77 /

-0.15 (-1.16%)

Recommendations
Spotify price target raised to $305 from $185 at JPMorgan » 06:44
07/06/20
07/06
06:44
07/06/20
06:44
SPOT

Spotify

$271.59 /

+12.63 (+4.88%)

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

06:16 Today Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
05:17 Today Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
07/01/20 Wells Fargo
Spotify price target raised to $175 from $130 at Wells Fargo
06/30/20 Citi
Spotify initiated with a Neutral at Citi
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

Syndicate
PG&E files to sell up to 819M shares for holders  06:43
07/06/20
07/06
06:43
07/06/20
06:43
PCG

PG&E

$9.44 /

+0.405 (+4.49%)

 
ShowHide Related Items >><<
PCG PG&E
$9.44 /

+0.405 (+4.49%)

PCG PG&E
$9.44 /

+0.405 (+4.49%)

06/24/20 Vertical Research
PG&E initiated with a Buy at Vertical Research
06/23/20 Seaport Global
PG&E initiated with a Neutral at Seaport Global
06/10/20 Barclays
PG&E price target raised to $16 from $15 at Barclays
06/09/20 Morgan Stanley
PG&E updated financing plan offers less downside risk, says Morgan Stanley
PCG PG&E
$9.44 /

+0.405 (+4.49%)

  • 26
    Jun
PCG PG&E
$9.44 /

+0.405 (+4.49%)

PCG PG&E
$9.44 /

+0.405 (+4.49%)

PCG PG&E
$9.44 /

+0.405 (+4.49%)

Syndicate
Akero Therapeutics files to sell 4.75M shares of common stock » 06:41
07/06/20
07/06
06:41
07/06/20
06:41
AKRO

Akero Therapeutics

$33.13 /

-0.36 (-1.07%)

JPM,Morgan Stanley,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

AKRO Akero Therapeutics
$33.13 /

-0.36 (-1.07%)

Initiation
Stifel starts Vroom at Buy, sees premium as justified » 06:41
07/06/20
07/06
06:41
07/06/20
06:41
VRM

Vroom

$54.21 /

+0.045 (+0.08%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$54.21 /

+0.045 (+0.08%)

06:40 Today JMP Securities
Vroom initiated with an Outperform at JMP Securities
06:19 Today Wells Fargo
Vroom initiated with an Overweight at Wells Fargo
04:48 Today Baird
Vroom initiated with an Outperform at Baird
04:46 Today Stifel
Vroom initiated with a Buy at Stifel
  • 09
    Jun
VRM Vroom
$54.21 /

+0.045 (+0.08%)

VRM Vroom
$54.21 /

+0.045 (+0.08%)

Recommendations
Tesla price target raised to $295 from $275 at JPMorgan » 06:41
07/06/20
07/06
06:41
07/06/20
06:41
TSLA

Tesla

$1,208.00 /

+88.84 (+7.94%)

JPMorgan analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

  • 14
    Feb
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

Initiation
Vroom initiated with an Outperform at JMP Securities » 06:40
07/06/20
07/06
06:40
07/06/20
06:40
VRM

Vroom

$54.21 /

+0.045 (+0.08%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$54.21 /

+0.045 (+0.08%)

06:19 Today Wells Fargo
Vroom initiated with an Overweight at Wells Fargo
04:48 Today Baird
Vroom initiated with an Outperform at Baird
04:46 Today Stifel
Vroom initiated with a Buy at Stifel
07/05/20 Goldman Sachs
Vroom initiated with a Neutral at Goldman Sachs
  • 09
    Jun
VRM Vroom
$54.21 /

+0.045 (+0.08%)

VRM Vroom
$54.21 /

+0.045 (+0.08%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.